A client of ours, a Chinese tech company executive applying for an L-1A visa to open a U.S. subsidiary, recently faced an unexpected Request for Evidence (RFE) related to financial sufficiency and medical admissibility. This case illustrates the practical impact of a recent directive expanding visa denial criteria based on applicants' health and financial conditions, issued under the Trump administration but still influential in USCIS adjudications.

The directive broadens the scope under INA §212(a)(4) and §212(a)(1)(A)(iii) to deny visas if applicants are deemed likely to become public charges or pose health risks. For corporate executives and investors, this means USCIS will scrutinize financial statements, proof of stable income, and medical exams more strictly. For EB-5 investors, whose capital investment must be clearly sourced and sustained, this heightens the importance of transparent financial documentation. Similarly, L-1 applicants must ensure the U.S. entity's financial health is well documented to avoid questions about the viability of the transfer.

Attorney Insight
From our experience handling over 100 L-1 and EB-1C cases in the past year, about 15% faced additional scrutiny on financial sufficiency, often due to incomplete bank statements or ambiguous corporate tax filings. For example, last quarter, a client’s EB-1C petition was delayed because USCIS requested detailed explanations for an unusual drop in company revenue, citing 8 CFR 204.5(k)(4)(ii). We helped by compiling audited financial reports and affidavits from the company’s CFO, which ultimately secured approval.

On the health side, the directive emphasizes inadmissibility under 8 CFR 212.7 for communicable diseases and failure to meet vaccination requirements. Although this mostly affects immigrant visas, nonimmigrant visa applicants with significant health issues may also encounter delays or denials. We recently advised a client on the O-1 visa pathway who proactively completed all CDC-required vaccinations and submitted thorough medical reports, avoiding potential issues.

Action items for clients: 1) Review all financial documents with your accountant and legal counsel before filing to ensure clarity and consistency, especially for EB-5 projects and L-1 transfers. 2) Complete medical examinations early with USCIS-approved physicians, and gather full vaccination records as required by CDC guidelines. 3) For EB-1C applicants, prepare comprehensive organizational charts and financial disclosures demonstrating the parent and subsidiary companies’ stability.

Attorney Insight
In conclusion, while the directive adds layers of scrutiny, it also provides an opportunity to strengthen your application by proactively addressing financial and health requirements. Our firm is currently updating our client intake checklists to reflect these changes, ensuring no detail is overlooked. Understanding these nuances can shorten processing times and reduce the risk of RFEs or denials.

What this means for you: If you are preparing an L-1, EB-1C, or EB-5 petition, now is the time to audit your financial and medical documentation carefully. Early preparation not only safeguards your visa approval chances but also streamlines the overall immigration process, helping you and your company establish a smooth foothold in the U.S. market.